Hybio Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year of 2015; Announces Management Changes
The company also approved the resignation of Yu Xiufeng as independent director, and elected Cao Dieyun as independent director.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.77 CNY | -0.08% |
|
+7.98% | -13.33% |
May. 29 | 3SBIO Unit to Cooperate on Development, Sale of Weight Management Injection | MT |
May. 29 | Hybio Pharmaceutical Grants Commercial Rights of Weight Loss Drug to Sansheng Mandi Pharmaceutical | MT |
1st Jan change | Capi. | |
---|---|---|
-13.33% | 1.43B | |
+16.80% | 43.26B | |
+17.47% | 21.6B | |
+21.73% | 15.93B | |
+23.95% | 15.1B | |
+57.96% | 12.95B | |
-0.05% | 6.79B | |
-16.22% | 6.29B | |
+21.38% | 6.04B | |
-8.87% | 5.73B |